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Abstract
Autophagy is a conserved catabolic process that delivers cytoplasmic components and
organelles to lysosomes for degradation and recycling. This pathway serves to degrade
nonfunctional organelles and aggregate-prone proteins, as well as to produce substrates for
energy production and biosynthesis. Autophagy is especially important for the maintenance
of stem cells, and for the survival and homeostasis of post-mitotic cells like neurons.
Functional autophagy promotes longevity in several model organisms. Autophagy regulates
immunity and inflammation at several levels and has both anti- and pro-tumorigenic roles in
cancer. This review provides a concise overview of autophagy and its importance in cellular
and organismal homeostasis, with emphasis on aging, stem cells, neuronal cells, immunity,
inflammation, and cancer.
1. Introduction
In autophagy, cells transport their own cytoplasmic material and organelles to lysosomes for
degradation and recycling. Basal autophagy functions in intracellular quality control by
degrading defective organelles and aggregate-prone proteins. Induced autophagy is initiated
as a survival mechanism by stress such as starvation; by degrading redundant components,
cells can produce nutrients and building blocks such as amino acids. Cytoplasmic material can
be transported to lysosomes via three different paths (Galluzzi et al., 2017a). In
macroautophagy, the first step is the engulfment of cytosolic cargo into membrane-bound
autophagosomes (Figure 1). Autophagosomes then fuse with lysosomes and deliver their
cargo for degradation and recycling (Mercer et al., 2018). In microautophagy, the endosomal
or lysosomal limiting membrane internalizes the cytoplasmic cargo in a process topologically
similar to endocytosis. The intraendosomal or intralysosomal cargo-containing vesicles are
then degraded by the lysosomal hydrolases (Tekirdag and Cuervo, 2018). The third autophagic
pathway is called chaperone-mediated autophagy (CMA), since it is assisted by cytoplasmic
and lysosomal chaperones. The cargo proteins of CMA contain a signal sequence similar to
the canonical KFERQ-sequence, which is recognized by the cytosolic chaperone HSC70 and its
co-chaperones. The cargo-chaperone complex is recognized by a lysosomal receptor, the
lysosome-associated membrane protein 2A (LAMP2A). LAMP2A and cytoplasmic as well as
lysosomal chaperones mediate the unfolding and transport of the cargo protein through the
lysosomal membrane (Kaushik and Cuervo, 2018).
The macroautophagic pathway is presented in Figure 2. Autophagosomes are formed by flat
membrane cisterns called phagophores or isolation membranes. When the phagophore seals
to engulf the cytoplasmic cargo, the resulting autophagosome has two lipid bilayers around
it. The outer limiting membrane of the autophagosome then fuses with endosomes and finally
with lysosomes. After fusion with endosomes, autophagosomes become amphisomes. Fusion
with lysosomes produces autolysosomes. The cytoplasmic cargo, still surrounded by the inner
limiting membrane of the autophagosome, is delivered to the lysosome. The limiting
membrane must be degraded or at least permeabilized before the lysosomal hydrolases will
be able to degrade the cargo. Macromolecules liberated in the degradation process are
transported back to cytoplasm by pumps on the lysosomal membrane. Autolysosomes have
at least two alternative clearance possibilities which are not mutually exclusive.
Autolysosomes may fuse with the plasma membrane and empty their contents to the
extracellular space (Medina et al., 2011). Another possibility is that lysosomes reform from
autolysosomes (Yu et al., 2010).
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2. Autophagy proteins regulate autophagosome biogenesis
Autophagy (atg) genes and proteins were originally discovered using yeast mutants (Baba et
al., 1997; Thumm et al., 1994; Tsukada and Ohsumi, 1993), and corresponding genes and
proteins were later found to function in mammalian cells. Upon autophagy initiation, ULK1
kinase complex, consisting or ULK1, ATG13, RB1CC1/FIP200 and ATG101, becomes active and
translocates to the endoplasmic reticulum (ER) (Figure 3). The next step is the recruitment of
the autophagy-specific phosphoinositide 3-kinase (PI3K) complex, containing the class III PI3-
kinase PIK3C3/VPS34, PIK3R4/VPS15, Beclin1, ATG14, and other proteins. This leads to the
production of PI3P and formation of omegasomes, specific ER subcompartments where
autophagosome biogenesis occurs (Axe et al., 2008). Omegasomes are characterized by the
PI3P-binding marker protein ZFYVE1/DFCP1. PI3P also recruits WIPI proteins to the forming
phagophores. ATG12-ATG5 conjugates, which form larger complexes by binding to ATG16,
are also recruited to the phagophores.  WIPI proteins and the ATG12-ATG5-ATG16 complex
promote lipidation of ATG8 homologs including LC3. LC3 is a widely used autophagosome
marker protein, and its lipidated, phagophore-associated form is called LC3-II. The
mammalian ATG8 protein family contains three LC3 forms (A, B, and C), GABARAP,
GABARAPL1 and GABARAPL2/GATE-16. ATG9 is the only transmembrane protein among
mammalian core autophagy proteins. ATG9 vesicles are known the play a role in
autophagosome biogenesis, but the details of this role are not fully understood. ATG9 is
recruited to the site of autophagosome formation either from the Golgi complex or from
recycling endosomes. Recent review articles describe the current knowledge on autophagy
proteins in more detail (Dikic and Elazar, 2018; Mercer et al., 2018; Wen and Klionsky, 2016).
Origin of autophagosome membranes has been investigated since autophagy was first
described in late 1950’s. Current view is that phagophores acquire membrane from several
sources including ER, ER exit sites, mitochondria, ER-Golgi intermediate compartment, Golgi
complex, recycling endosomes and plasma membrane. Membrane contact sites with any of
the above organelles may also be involved in phagophore biogenesis. Origin of phagophore
membranes is discussed in detail in several excellent reviews (Ktistakis and Tooze, 2016; Mari
et al., 2011; Soreng et al., 2018; Yu et al., 2018). Maturation of autophagosomes to
degradative autolysosomes depends on the small GTPase RAB7, its guanine nucleotide
exchange factor CCZ1-MON1, the HOPS complex as well as syntaxin 17 and other SNARE
proteins. Details of autophagosome maturation to autolysosomes are described in several
recent reviews (Ktistakis and Tooze, 2016; Soreng et al., 2018; Yu et al., 2018; Zhao and Zhang,
2018; Zhao and Zhang, 2019).
Autophagy is stimulated by different stress conditions, of which amino-acid starvation is
currently best understood. Lack of amino acids, oxygen, energy or growth factors inactivate
the nutrient sensing protein kinase mTORC1, and as a consequence of this, mTORC1 sites of
ULK1 become dephosphorylated. ULK1 then undergoes autophosphorylation. ULK1 also
phosphorylates ATG13 and FIP200, the other components of the ULK1 complex, which
stimulates the ULK1 kinase activity and the translocation of the ULK1 complex to the
omegasome. Transcription factor EB (TFEB) is a key regulator of autophagy and lysosome
biogenesis. TFEB is negatively regulated by mTORC1 activity, and during amino-acid
starvation, TFEB is released from the inhibition to enhance the expression of autophagy and
lysosomal genes. Autophagy is also induced by decreasing energy levels, e.g. during glucose
starvation, which is sensed via ATP/AMP ratio by AMPK (AMP-activated protein kinase) as
well as the serine/threonine-protein kinase LKB1 (also called STK11). AMPK can mediate
autophagy induction either via mTORC1, or directly by inducing phosphorylation of ULK1,
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VPS34, and Beclin1. A recent study revealed a new aspect in autophagy regulation. Autophagy
induction was shown to depend on the eukaryotic translation initiation factor 5A (eIF5A),
which is necessary for the translation of ATG3 (Lubas et al., 2018). ATG3 is one of the E2-like
enzymes that mediate lipid conjugation to LC3B and other ATG8 family proteins. mTORC1
inhibition was shown to enhance the association of eIF5A with ribosomes. Autophagy
signaling in described in more detail in several reviews (Damme et al., 2015; Gallagher et al.,
2016; Rabanal-Ruiz et al., 2017; Zachari and Ganley, 2017).
Starvation-induced macroautophagy is considered to be unselective with respect to the
cytoplasmic cargo. However, recent studies have revealed several selective modes of
macroautophagy, including mitophagy (selective for mitochondria), aggrephagy
(aggregates), reticulophagy or ER-phagy (endoplamic reticulum, ER), ribophagy (ribosomes),
lipophagy (lipid droplets), lysophagy (damaged lysosomes), pexophagy (peroxisomes), and
xenophagy (intracellular pathogens). The selectivity is mediated by autophagy receptors that
have domains binding to one or more of the ATG8 homologs localized on the phagophore
membrane, as well as domains binding to the cargo (Figure 4). Part of autophagy receptors
recognize ubiquitin on the cargo, while others bind the cargo independent of ubiquitination
(Khaminets et al., 2016). Ubiquitin-dependent autophagy receptors include SQSTM1/p62,
NBR1, OPTN (optineurin) and CALCOCO2/NDP52, while ubiquitin-independent receptors
include NIX, BNIP3, FUNDC1, RETREG1/FAM134B and galectin 8. One autophagy receptor can
play a role in several types of selective autophagy, and one type of selective autophagy can
be mediated by several receptors.  A more complete description of autophagy receptors is
presented in (Khaminets et al., 2016).
3. Autophagy supports cellular and organismal homeostasis
Autophagy maintains intracellular energy homeostasis and protects cells against stress. Post-
mitotic cells like neurons and muscle cells are particularly dependent on autophagic clearance
of defective organelles and aggregated proteins, since they are not able to renew their
cytoplasm by cell division (Damme et al., 2015).  Autophagy has been shown to support the
health of both cells and organisms, and defects in autophagy lead to diseases including
neurodegeneration, muscle diseases, cancer, immunological disorders and metabolic
diseases (Dikic and Elazar, 2018; Levine and Kroemer, 2008; Levine and Kroemer, 2019).
Several neurodegenerative diseases are connected to defective autophagy including
Parkinson’s, Alzheimer’s, and Huntington’s diseases and amyotropic lateral sclerosis (ALS)
(Damme et al., 2015; Dikic and Elazar, 2018; Nixon, 2013; Wong and Holzbaur, 2015). Further,
several studies have shown that functional autophagy can extend lifespan in different model
organisms (Fernandez et al., 2018; Madeo et al., 2015; Melendez et al., 2003). However, the
role of autophagy in cancer is context dependent. By clearing defective mitochondria that are
a source of reactive oxygen species, autophagy inhibits tumor formation by decreasing
oxidative stress (White et al., 2015). In addition, autophagy inhibits tumorigenesis by
regulating inflammation and immunity (Zhong et al., 2016a). On the other hand, cancer cells
can utilize autophagy to support their energy balance in order to survive stress, and increased
autophagy has been connected to metastasis (Mowers et al., 2016; White et al., 2015). Figure
5 summarizes the functions of autophagy at cellular and organismal levels. The current
knowledge on the role of autophagy in aging, neurodegeneration, immunity and cancer is
discussed in more detail in the following paragraphs.
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4. Aging, lifespan and stem cells
During aging, cells accumulate genetic and oxidative damage, which ultimately leads to the
death of the organism. Several studies with model systems including yeast, Caenorhabditis
elegans, Drosophila melanogaster and mice have shown that autophagy-related genes are
required for lifespan extension under different longevity conditions, while autophagy-
deficiency has less effect on normal lifespan (Hansen et al., 2018; Melendez et al., 2003;
Nakamura and Yoshimori, 2018). Further, long-lived mutant animals display increased steady-
state levels of autophagy proteins, suggesting increased autophagy activity. Both
macroautophagy and chaperone-mediated autophagy activities decline when animals age,
due to decrease in autophagy gene expression. On the other hand, overexpression of
autophagy genes has been shown to extend the lifespan in several species. For example,
overexpression of Atg8a in the nervous system of Drosophila extends the lifespan of the flies
(Simonsen et al., 2008). Further, overexpression of the Drosophila transcription factor hlh-30
(TFEB in mammals), which regulates many autophagy and lysosomal genes, extends lifespan
of the animals (Lapierre et al., 2013).
Specific constitutive activation of basal autophagy was recently studied in mice. The activation
was achieved by introducing a point mutation, F121A, in Beclin1. The mutation impairs the
binding of Beclin1 to BCL2, which would prevent Beclin1 function in autophagy. Remarkably,
the Beclin1 mutation increased basal autophagic flux and prolonged the median survival of
both male and female mice by 12% (Fernandez et al., 2018). Further, age-related renal and
cardiac pathologies and spontaneous tumors were decreased in the mutant mice. Thus,
increased basal autophagy increased both lifespan and healthspan in mice. Another recent
study demonstrated the longevity-promoting effects of a natural flavonoid, 4,4ʹ-
dimethoxychalcone (DMC), in several species (Carmona-Gutierrez et al., 2019). DMC induces
autophagy, and this induction was shown to be essential for its cytoprotective effects. DMC
induced a conserved, systemic change in metabolism, which was independent of mTORC1,
but instead depended on GATA transcription factors.
It has been established that autophagy activity declines with aging, but until recently, the
underlying mechanisms of the decline were not known. A recent study showed that the
expression of Rubicon, a negative regulator of autophagy, increases at both mRNA and
protein levels in tissues of aged C. elegans, Drosophila, and mouse (Nakamura et al., 2019).
Knockdown of Rubicon increased the lifespan of worms and flies, and in addition, several age-
associated phenotypes decreased. Notably, knockdown of Rubicon in neurons was most
effective in extending the lifespan. Rubicon knockout mice showed reduced fibrosis in the
kidneys and decreased accumulation of a-synuclein in the brain. The authors conclude that
inhibition of autophagy by increased levels of Rubicon is one of the signatures of aging.
A recent study showed that autophagy induction in hippocampal neurons is required to
promote memory in mice (Glatigny et al., 2019). Autophagy was shown to promote activity-
dependent structural and functional synaptic plasticity. Further, hippocampal autophagy was
observed to decline with aging, and remarkably, restoring autophagy activity in old mice was
sufficient to reverse age-related memory decline. Of note, the bone-derived molecule
osteocalcin was identified as a direct hormonal inducer of hippocampal autophagy.
Stem cells have the ability to undergo both self-renewal and differentiation into different cell
types. Like all cells, stem cell undergo aging and can lose their ability for self-renewal and/or
differentiation, and this is associated with decline of organ functions during aging of the
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organism. Basal autophagy is very active in different types of stem cells (Pan et al., 2013), and
it is required for quality control, energy production, and metabolic reprogramming (Levine
and Kroemer, 2019). Stem cells utilize autophagy to maintain their regenerative capacity, and
autophagy is also activated during differentiation (Boya et al., 2018; Garcia-Prat et al., 2016a;
Garcia-Prat et al., 2017; Guan et al., 2013). The regenerative capacity of muscle stem cells
declines with aging, when the cells transition from quiescence to irreversible senescence
(Garcia-Prat et al., 2016b). Basal autophagy was shown to be essential for the maintenance
of quiescence in mice, and failure of autophagy caused senescence by mitochondrial
dysfunction, oxidative stress, and loss of proteostasis. Similarly, autophagy is indispensable
for the maintenance of hematopoietic stem cells (Mortensen et al., 2011). Interestingly, in
hematopoietic stem cells, autophagy was shown to suppress metabolism by degrading
healthy, active mitochondria, in order to maintain quiescence and stemness, while loss of
autophagy caused metabolic activation and loss of stemness (Ho et al., 2017). Neural stem
cells also depend on autophagy for both self-renewal and differentiation (Boya et al., 2018).
5. Neurodegeneration
Under physiological conditions, neurons have a relatively high level of basal autophagy
(Nikoletopoulou et al., 2015). One of the hallmarks of several neurodegenerative diseases is
the accumulation of unfolded or misfolded proteins in neuronal cells, which disrupts cell
functions and eventually leads to cell death (Boland et al., 2018). The role of autophagy in
neurons has been demonstrated using neural-cell-specific knockout of autophagy proteins
(ATG5, ATG7 or FIP200/RB1CC1) that are indispensable for autophagosome formation (Hara
et al., 2006; Komatsu et al., 2006; Liang et al., 2010). Shortened lifespan and progressive
motor and behavioral defects were observed in the mutant mice. The animals showed severe
neurodegeneration and histological analysis revealed accumulation of ubiquitin-positive
aggregates in neurons.
Dysfunctional mitochondria are another major cause for neurodegeneration, since they
produce reactive oxygen species that damage proteins, lipids, carbohydrates, and nucleic
acids (Birben et al., 2012; Joshi and Mochly-Rosen, 2018). Several proteins with
neurodegenerative disease-causing mutations have been connected to autophagy, especially
mitophagy, or lysosomal function (Gan-Or et al., 2015; Levine and Kroemer, 2019; Trinh and
Farrer, 2013). Accumulating evidence indicates that active autophagy is beneficial in
preventing neurodegeneration. Accordingly, autophagy induction is explored as a way to
treat or prevent neurodegenerative diseases (Boland et al., 2018; Dikic and Elazar, 2018). The
role of autophagy in three major neurodegenerative diseases, Parkinson’s disease,
Alzheimer’s disease, and amyotropic lateral sclerosis, is discussed in more detail below.
5.1. Parkinson’s disease
Increasing evidence shows that lysosomal and autophagosomal dysfunction and the
development of Parkinson’s disease are closely linked (Lynch-Day et al., 2012). Two proteins
that function in mitophagy, PTEN-induced putative kinase 1 (PINK1) and the ubiquitin ligase
Parkin, are strongly associated with early-onset Parkinson’s disease (Hernandez et al., 2016).
Depolarization of mitochondria initiates a cascade on the mitochondrial surface, including
PINK1-mediated phosphorylation and Parkin-mediated ubiquitination, which leads to
recruitment of autophagy machinery to the mitochondrion (Pickles et al., 2018). Several other
Parkinson’s disease-associated proteins also function in autophagy or lysosomes including
LRRK2, ATP13A2 and GBA (Hernandez et al., 2016). LRRK2 (leucine-rich repeat kinase 2) is a
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large multi-domain protein implicated in several cellular functions including autophagy
(Manzoni and Lewis, 2017), mitochondrial function, and vesicular trafficking. Disease-causing
mutations of ATP13A2 (lysosomal type 5 ATPase) impair lysosomal acidification and
proteolytic activity, thereby also decreasing autophagic flux and the clearance of a-synuclein
aggregates, which typically accumulate in neurons in Parkinson’s disease (Dehay et al., 2012).
Aggregation of a-synuclein eventually disturbs neuronal function and leads to cell death.
ATP13A2 was also recently shown to promote autophagosome-lysosome fusion (Wang et al.,
2018). Glucocerebrosidase (GBA) is a lysosomal enzyme required for the degradation of
glucocerebroside to ceramide. Knockdown of GBA in cortical neurons was shown to cause
accumulation of a-synuclein (Mazzulli et al., 2011). Notably, homozygous or heterozygous
GBA mutations are associated with 20-fold increase in the risk of Parkinson’s disease
(Schapira, 2015).
a-Synuclein contains the KFERQ-sequence that acts as a zip code for CMA, and accordingly,
a-synuclein has been shown to be turned over via CMA (Cuervo et al., 2004). Further, other
studies have shown that also macroautophagy is beneficial for cells expressing mutant a-
synuclein. Induction of macroautophagy by overexpression of Beclin1 or rapamycin treatment
could rescue a-synuclein degradation in neuronal cell lines overexpressing a-synuclein
(Spencer et al., 2009). Lentivirus-mediated overexpression of Beclin1 also decreased the
Parkinson’s disease pathology of a-synuclein transgenic mice. These results suggest that both
CMA and macroautophagy contribute to the turnover of a-synuclein. Prolyl oligopeptidase
enzyme has the ability to accelerate a-synuclein aggregation, and an inhibitor of prolyl
oligopeptidase activity, KYP-2047, was demonstrated to decrease the amount of a-synuclein
aggregates in cell cultures and a-synuclein transgenic mice (Savolainen et al., 2014; Svarcbahs
et al., 2016). Importantly, cell culture experiments indicated that KYP-2047 accelerated the
clearance of a-synuclein aggregates by increasing autophagy (Savolainen et al., 2014).
5.2. Alzheimer’s disease
Alzheimer’s disease is characterized by the accumulation of amyloid b-peptide and Tau in
neurons (Boland et al., 2018; Hamano et al., 2018; Xin et al., 2018). Both autophagy and
proteasomes have been implicated in the normal intracellular clearance of these two
proteins. A recent study analyzed transcriptomics data of post-mortem brains of Alzheimer’s
and type 2 diabetes patients. Data analysis indicated a principal role for autophagy
dysfunction in both diseases (Caberlotto et al., 2019). The role of autophagy-related genes
was confirmed using an Alzheimer mouse model. Cholesterol accumulation is another
symptom common to many neurodegenerative diseases including Alzheimer’s disease. High
brain cholesterol levels in an Alzheimer mouse model were shown to enhance
autophagosome formation but inhibit their fusion with endosomes and lysosomes, which
resulted in impaired clearance of both amyloid b-peptide and Tau (Barbero-Camps et al.,
2018). Hyperphosphorylation of Tau protein leads to the formation of aggregates called
neurofibrillary tangles, and autophagy has been implicated in the removal of these
aggregates. Selective autophagy was recently shown to protect cells against seeded Tau
aggregation (Falcon et al., 2018). Tau assemblies move from cell to cell by exocytosis and
endocytosis. The endocytosed Tau assemblies escape to the cytosol by damaging the
endosomal membrane. However, the danger receptor galectin-8 detects the damaged
endosomes and initiates selective autophagy, thus limiting the release of Tau assemblies into
the cytosol where they would act as seeds for larger aggregates. Another study showed that
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Tau has the potential to inhibit mitophagy by reducing the recruitment of Parkin to damaged
mitochondria (Cummins et al., 2018).
Amyloid precursor protein is processed in cells by BACE1 and g-secretase. The cleavage by
BACE1, followed by g-secretase,  produces the harmful amyloid b 40 and 42 peptides.  A
recent study asked how  g-secretase processing of amyloid precursor protein affects
autophagy and lysosomal functions in monogenic Alzheimer’s disease (Hung and Livesey,
2018). Neurons with mutations in amyloid precursor protein and presenilin1, another protein
linked to Alzheimer’s disease, were demonstrated to have defects in lysosomal proteolysis
and autophagosome clearance. The rapid appearance of these defects was interpreted to
indicate that they are causes, rather than consequences, of neuronal dysfunction. When
BACE1 enzyme was inhibited, lysosome function was restored in both amyloid precursor
protein and presenilin1 mutant neurons. Further, presenilin1 mutant phenotype was rescued
by deletion of amyloid precursor protein.  Another recent study showed that expression of
Alzheimer’s disease mutant amyloid precursor protein in primary mouse hippocampal
neurons induced defects in autophagy, mitophagy and mitochondrial functions (Reddy et al.,
2018). Further, mutations in presenilin1 have been implicated in impaired lysosomal
acidification, due to disturbed transport of a v-ATPase subunit from the ER to lysosomes (Lee
et al., 2010). Impaired lysosomal acidification causes accumulation of autolysosomes in the
cytoplasm, which disturbs neuronal functions.
5.3. Huntington’s disease
Huntington’s disease is a hereditary disorder caused by expanded GAG trinucleotide repeats
in the gene encoding Huntingtin protein. Huntingtin is a large protein with several proposed
functions including endocytosis, vesicle transport and autophagy (Harjes and Wanker, 2003).
The expanded polyglutamine repeats in Huntingtin make the protein prone to aggregation.
Polyglutamine-containing Huntingtin is normally turned over via autophagy (Ravikumar et al.,
2002; Yamamoto et al., 2006), and autophagy induction has been shown to reduce toxicity of
polyglutamine proteins in Huntington animal models (Ravikumar et al., 2004). Huntingtin has
been demonstrated to function as an adaptor protein in selective autophagy (Rui et al., 2015).
Huntingtin was shown to participate in SQSTM1-mediated cargo recognition by facilitating
the binding of SQSTM1 to polyubiquitinated proteins. Further, by interacting with ULK1,
Huntingtin was able to dissociate ULK1 from its inhibitory interaction with mTORC1. Another
study showed that ULK1-mediated autophagy induction is disturbed in a Huntington mouse
model (Wold et al., 2016). Further, polyglutamine extension in Huntingtin was shown to
competitively disturb the interaction of Beclin1 with the deubiquitinase ataxin3. This
disruption lead to proteasomal degradation of Beclin1, which decreased autophagosome
formation (Ashkenazi et al., 2017).
To summarize the studies described above, aggregated polyglutamine-containing Huntingtin
is less able to carry out its functions in autophagy, which enhances its accumulation in cells.
In agreement with this, a recent study demonstrated that aggregated Huntingtin inhibits
autophagy in neuronal cells. This lead to accumulation of Argonaute-2, a protein that executes
microRNA functions. Thus, impaired autophagy due to Huntingtin aggregation caused a global
dysregulation of microRNAs in neurons (Pircs et al., 2018). The deubiquitinase USP12 was
recently shown to induce autophagy and protect neurons in Huntington’s disease models
(Aron et al., 2018). USP12 overexpression was demonstrated to increase autophagic flux in
neurons approximately six-fold, while suppression of endogenous USP12 inhibited
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autophagy. Notably, catalytic activity of USP12 was dispensable for its neuroprotective and
autophagy-inducing functions.
5.4. Amyotrophic lateral sclerosis (ALS)
Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease that involves loss of motor
neurons in the spinal cord and brain. Deficiency of autophagy and/or mitophagy has been
implicated in this disease (Evans and Holzbaur, 2018).  ALS is characterized by accumulation
of protein aggregates containing Tar-DNA binding protein 43 (TDP-43) as well as abnormal
mitochondria in motor neurons (Taylor et al., 2016). A large number of different genes have
been implicated in the hereditary forms of ALS. These genes are associated with differing
cellular functions including ribosome/RNA function, proteostasis, mitochondrial function,
cytoskeleton, and intracellular traffic. Notably, several of the ALS-associated proteins have
connections to autophagy and/or mitophagy, including autophagy receptors SQSTM1,
optineurin and ubiquilin2, as well as TBK1 (tank binding kinase 1) that functions in mitophagy
and xenophagy (Damme et al., 2015; Ravenhill et al., 2019; van Beek et al., 2018). A recent
study showed that the autophagy receptor NDP52 binds TBK1, and this complex targets ULK1
to mitochondria, in order to initiate mitophagy (Vargas et al., 2019). In addition to their
autophagy cargo receptor function, SQSTM1, optineurin and ubiquilin2 also act in the
degradation of substrates via the proteasome system.
The most common genetic cause of ALS and the related disorder, frontotemporal dementia
(FTD), is the expansion of a hexanucleotide repeat in a non-coding region of the gene C9orf72.
The C. elegans orthologue of this gene product was shown to function in degradation of
endosomal and lysosomal content and in lysosome reformation, and defects in its function
lead to defects in the clearance of autophagosomal cargo (Corrionero and Horvitz, 2018).
Another protein mutated in TDP-43 proteinopathies is the valosin-containing protein (VCP).
VCP is a member of the AAA+-ATPase (ATPase associated with diverse cellular activities)
protein super family (Johnson et al., 2010). Mutations in VCP lead to impaired fusion of
autophagosomes with lysosomes (Ju et al., 2009; Tresse et al., 2010).
6. Immunity, infection and inflammation
Autophagy has been implicated in several immune functions including removal of intracellular
pathogens, cytokine secretion, inflammation, antigen presentation and lymphocyte
development. Xenophagy, a type of selective autophagy, participates in innate immunity by
targeting certain intracellular pathogens for degradation in lysosomes (Gkikas et al., 2018).
The first observations on xenophagy were reported for intracellular group A Streptococcus,
which were shown to be selectively targeted by autophagy (Nakagawa et al., 2004). Other
intracellular bacteria including Listeria, Salmonella, Legionella and Shigella are degraded by a
similar xenophagy mechanism (Gomes and Dikic, 2014). Similar to other types of selective
autophagy, xenophagy is mediated by autophagy receptor proteins including SQSTM1, NBR1,
NDP52 and optineurin. Some pathogens are able to modify the xenophagic or phagocytic
processes in a way that allows them to survive and multiply inside these cellular
compartments. Mycobacterium tuberculosis persists inside phagosomes in phagocytic cells by
interfering with the biogenesis of degradative phagolysosomes. This interference could be
rescued by stimulating autophagy in macrophages (Gutierrez et al., 2004). Autophagy
induction resulted in the recruitment of the autophagy protein LC3 to the bacteria-containing
phagosomes, which facilitated fusion of the phagosomes with lysosomes. This type of
phagocytosis is called LC3-associated phagocytosis (LAP) (Martinez, 2018).
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The molecular mechanisms of xenophagy and mitophagy are remarkably similar, including
participation of autophagy receptors and the Parkin ubiquitin ligase (Gkikas et al., 2018).
Mitophagy also plays an important role in inflammation. By removing damaged mitochondria,
mitophagy prevents the accumulation of depolarized mitochondria that are a source of
reactive oxygen species and oxidized mitochondrial DNA, which would activate inflammatory
signaling, leading to chronic inflammation (Gkikas et al., 2018; Nakahira et al., 2011; Zhong et
al., 2016b). Autophagy can also selectively degrade inflammasome components (Deretic and
Levine, 2018).  TRIM proteins are autophagy receptors that have been demonstrated to play
a role in autophagic degradation of several inflammasome proteins (Kimura et al., 2015).
Autophagy is also involved in antigen presentation by MHC-II molecules in macrophages,
dendritic cells and thymic epithelial cells. Autophagosomes containing degraded pathogens
or intracellular antigens fuse with the cellular compartments where MHC-II loading occurs
(Kinsella et al., 2018; Paludan et al., 2005; Schmid et al., 2007). A recent study revealed yet
another aspect in the interplay between autophagy and immunity.  CD4+ T cells upregulate
autophagy in response to activation.  T cells unable to induce autophagy after T cell receptor
activation showed defective signaling, leading to T cell anergy, a state of functional
inactivation. In a mouse model of autoimmune disease, the inability of T cells to upregulate
autophagy decreased the severity of the disease (Mocholi et al., 2018). Finally, autophagy
genes have been demonstrated to play different roles during the development of both B cells
and T cells (Kinsella et al., 2018).
Autophagy acts as an anti-inflammatory pathway, and defective autophagy has been
associated with susceptibility to autoimmune and chronic inflammatory diseases (Bonam et
al., 2018; Deretic and Levine, 2018; Levine and Kroemer, 2019; Yin et al., 2018). For example,
polymorphisms of autophagy genes are associated with susceptibility to the inflammatory
bowel disease called Crohn’s disease, and to the autoimmune disorder called systemic lupus
erythematosus (SLE). ATG16L1 is an autophagy protein that functions during autophagosome
biogenesis. Mutations in ATG16L1, especially T300A point mutation, are linked with Crohn’s
disease. ATG16L1 has a caspase-cleavage motif, and the T300A variant significantly increases
the susceptibility of the protein for caspase3 cleavage (Murthy et al., 2014). Mouse models
of Crohn’s disease were used to show that ATG16L1 can control inflammasome activation
(Cadwell et al., 2008; Saitoh et al., 2008). Mutations in ATG16L1 are also associated with
defects in innate immune response against enteric bacteria (Kinsella et al., 2018; Strisciuglio
et al., 2013). Further, a missense mutation in the autophagy receptor NDP52 is also associated
with Crohn’s disease (Ellinghaus et al., 2013). The mutation was shown to impair the function
of NDP52 in inhibiting the activation of inflammatory genes by NF-kB, and to have an effect
on the stability of Toll-like receptor pathway proteins.  IRGM is another established risk factor
for Crohn’s disease. IRGM was recently shown to inhibit NLRP3 inflammasome activation in
order to reduce inflammation (Mehto et al., 2019). Mechanistically, IRGM was demonstrated
to mediate selective autophagic elimination of the NLRP3 inflammasome.
Polymorphisms in ATG5, another protein that functions in autophagosome formation, are
associated with susceptibility to SLE, and several lines of evidence show that autophagy
contributes to the development of the disease (Ciccacci et al., 2018; Liu et al., 2016). The
pathogenesis of SLE is not understood, but there are numerous ways how autophagy could
influence the disease, and several autophagy-modulating drugs are used in clinical trials for
SLE (Liu et al., 2016). Of note, chaperone-mediated autophagy has been observed to be
hyperactivated in a subset of lymphocytes of SLE model mice. A peptide called P140 targets
this autophagy pathway, and treatment with P140 resulted in weaker signaling of
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autoreactive T cells and reduced symptoms in SLE model mice. The effect on T cell signaling
was confirmed using T cells of SLE patients (Monneaux et al., 2005; Monneaux et al., 2003).
Notably, in phase II clinical trials, P140 was able to significantly diminish the clinical
manifestations of SLE (Zimmer et al., 2013).
7. Cancer
The role of autophagy in cancer is complex and highly context dependent; autophagy can both
suppress and promote cancer progression (Dikic and Elazar, 2018; Yun and Lee, 2018). During
cancer initiation autophagy is considered anti-tumoral due to its role in protection against
metabolic, oxidative and inflammatory stress (Liang et al., 1999; Qu et al., 2003; Takamura et
al., 2011). At later stages of tumorigenesis and metastasis, both anti- and pro-tumoral roles
of autophagy have been reported, depending on the context.
The first findings connecting autophagy with cancer showed that monoallelic deletion of the
autophagy gene BECN1 are associated with breast and ovarian cancer (Levine and Kroemer,
2019; Liang et al., 1999). BECN1 heterozygous mice showed decreased autophagy and
increased incidence of tumors (Qu et al., 2003; Yue et al., 2003). Further, HER2, the oncogenic
receptor tyrosine kinase that is often overexpressed in aggressive tumors, was shown to
interact with Beclin1, and this interaction was shown to inhibit autophagy (Vega-Rubin-de-
Celis et al., 2018).  A recent study demonstrated another role for autophagy in tumor
suppression. Replicative crisis prevents oncogenic transformation by eliminating pre-
cancerous cells that have lost their cell-cycle checkpoints. Autophagy was shown to play a
major role in the cell death during replicative crisis (Nassour et al., 2019). When autophagy
was suppressed, the cells were able to bypass the crisis, continued to proliferate, and
accumulated genome instability. Further, telomere dysfunction was demonstrated to trigger
autophagy.
Human cancers with activity-increasing HRAS and KRAS mutations often have increased levels
of basal autophagy, which maintains functional mitochondria and cellular metabolism.
Autophagy also supports survival during starvation that often occurs in the center of solid
tumors (Guo et al., 2011). The status of the tumor suppressor p53 was reported to determine
the role of autophagy in pancreatic tumorigenesis in mice (Rosenfeldt et al., 2013). The mice
had an oncogenic allele of KRAS in the pancreas, which lead to the appearance of a small
number of pre-cancerous lesions that proceeded to cancer over time. The progression to
cancer was not observed in mice lacking essential autophagy genes. However, if the mice
lacked p53, loss of autophagy did not block tumor progression. Another recent study revealed
a mechanism for the autophagy-dependency of KRAS-driven liver tumorigenesis: autophagy
was shown to control asparagine homeostasis (Lin et al., 2018). Autophagy-deficient tumors
suffered from asparagine deficiency and therefore grew more slowly, and the tumor cells also
showed reduced mitochondrial function. Further, another study showed that host-specific
autophagy deficiency impairs tumor growth due to reduction of circulating arginine (Poillet-
Perez et al., 2018). Glioblastoma is one of the most malignant forms of brain cancer due to
resistance to chemotherapy. This tumor type utilizes oxidative phosphorylation, aerobic
glycolysis, as well as autophagy to maintain its energy homeostasis (Zou et al., 2014). A recent
study showed that autophagy inhibition prior to chemotherapy was able to impair the
mitochondrial function and energy balance of the cancer cells, leading to apoptotic cell death
(Kriel et al., 2018).
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Autophagy also has a dual role in metastasis (Kenific et al., 2010). At early stages of
metastasis, autophagy is mainly anti-metastatic due to limitation of necrosis and
inflammation, while at later stages autophagy promotes metastasis due to promotion of
cancer cell survival. Autophagy enables extracellular-matrix-detached cancer cells to avoid
anoikis, cell death due to loss of anchorage (Guadamillas et al., 2011). Autophagy has also
been shown to assist the migration of metastatic tumor cells by recycling of focal adhesion
proteins (Sharifi et al., 2016). Autophagy inhibition was demonstrated to inhibit tumor cell
migration and invasion in vitro and retard metastasis in vivo. Another study showed that
autophagy inhibition decreased metastasis of osteosarcoma cells (Zhang et al., 2018). In
oncogenic-RAS-transformed epithelial cells, depletion of autophagy genes inhibited invasion
in vitro and metastasis in vivo (Lock et al., 2014). In the latter study, the increased invasive
capacity was shown to be due to autophagy-dependent secretion of the pro-migratory
cytokine interleukin 6.
Many forms of cancer therapy induce autophagy in tumor cells, which helps them to survive
stress caused by the treatment. Accordingly, inhibition of autophagy at the time of therapy
has been suggested to be beneficial for the treatment (Apel et al., 2008; Dikic and Elazar,
2018; Shingu et al., 2009). However, in other contexts, autophagy activation can be used to
enhance the effect of cancer therapy, as shown recently for glioblastoma (Kriel et al., 2018).
As discussed above, autophagy plays several roles in immunity, and activation of autophagy
has been suggested to be a way to enhance the effect of cancer immunotherapy (Galluzzi et
al., 2017b; Michaud et al., 2011). Cancer treatments can also activate a lethal type of
autophagy called autophagic cell death (Armstrong et al., 2015; Fulda, 2018).  Finally, as also
discussed above, autophagy plays a role in maintaining the fitness and pluripotency of stem
cells, including cancer stem cells, which contribute to chemoresistance (Sharif et al., 2017;
Smith and Macleod, 2018).
8. Conclusions
The significance of autophagy has been widely recognized in recent years, as evidenced by
the Nobel prize in medicine or physiology 2016, awarded to Yoshinori Ohsumi for his work on
the molecular mechanisms of autophagy (Mohammadi, 2016). Recent decades have
increased our understanding on the numerous roles of autophagy in aging, stem cell
maintenance, neuronal function, immunity, and inflammation. A growing number of studies
support the view that autophagy is beneficial for neurons, and induction of autophagy has
potential in treatment of neurodegenerative diseases. However, the role of autophagy in
initiation, establishment and metastasis of cancer is more complex and strongly context-
dependent. Further studies are needed in order to understand whether, and how, autophagy
could be exploited in cancer treatment.
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Figures
Figure 1. Schematic representation of the three autophagic pathways that deliver cargo from
cytoplasm to lysosomes.
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Figure 2. Schematic drawing of the macroautophagy pathway. Phagophores emerge between
two endoplasmic reticulum cisternae, and close to form autophagosomes. Autophagosomes
fuse with endosomes and lysosomes to mature into autolysosomes, which are the main
degradative compartment of the pathway. Lysosomes can reform from autolysosomes, and
autolysosomes can also fuse with the plasma membrane and empty their contents to the
extracellular space.
Figure 3. Overview of proteins, protein complexes and organelles that participate in
autophagosome formation. See text for further details.
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Figure 4. Schematic drawing of ubiquitin-dependent selective autophagy. Note that part of
the autophagy receptors are independent of cargo ubiquitination.
Figure 5. Summary of the functions of autophagy at cellular and organismal levels.
